Clinical Trial Update: Is Insulin Resistance and/or Glucose Intolerance Pathogenetic in the Development of a Reduced Incretin Effect [NA]

View source ↗

Summary

A completed clinical trial evaluating whether insulin resistance and/or glucose intolerance contribute to a reduced incretin effect.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose Intolerance
• Insulin Resistance

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Insulin Resistance, Glucose Intolerance | NA | Status: COMPLETED